ATE113989T1 - Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen. - Google Patents

Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen.

Info

Publication number
ATE113989T1
ATE113989T1 AT90101860T AT90101860T ATE113989T1 AT E113989 T1 ATE113989 T1 AT E113989T1 AT 90101860 T AT90101860 T AT 90101860T AT 90101860 T AT90101860 T AT 90101860T AT E113989 T1 ATE113989 T1 AT E113989T1
Authority
AT
Austria
Prior art keywords
hiv
seropositive
monoclonal antibody
differentiation
individuals
Prior art date
Application number
AT90101860T
Other languages
English (en)
Inventor
Jeffrey C Hunt
Virender K Sarin
Sushil G Devare
Suresh M Desai
Jill Johnson-Paepke
Ilse Ingrid E Tribby
James M Casey
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE113989T1 publication Critical patent/ATE113989T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90101860T 1989-02-03 1990-01-31 Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen. ATE113989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30636689A 1989-02-03 1989-02-03
US36173989A 1989-06-02 1989-06-02

Publications (1)

Publication Number Publication Date
ATE113989T1 true ATE113989T1 (de) 1994-11-15

Family

ID=26975121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90101860T ATE113989T1 (de) 1989-02-03 1990-01-31 Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen.

Country Status (8)

Country Link
US (1) US5374518A (de)
EP (1) EP0388602B1 (de)
JP (1) JP2958346B2 (de)
AT (1) ATE113989T1 (de)
AU (1) AU4906590A (de)
CA (1) CA2009198C (de)
DE (1) DE69013950T2 (de)
ES (1) ES2066887T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514691B1 (en) * 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
WO1992003579A1 (en) * 1990-08-16 1992-03-05 Diagnostic Biotechnology, Inc. An augmented western blot format and immunoassay for detection of viral antibodies
US5256561A (en) * 1991-12-20 1993-10-26 Abbott Laboratories Monoclonal antibody to HIV-2 and uses thereof
US6074646A (en) * 1993-10-26 2000-06-13 Board Of Regents, The University Of Texas System Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
EP0832113B1 (de) * 1995-06-07 2004-05-19 Abbott Laboratories Peptide zur detektion von hiv-1
DE19622088A1 (de) * 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben
EP0993615A1 (de) * 1998-03-04 2000-04-19 Universal Healthwatch, Inc. Schnelltest für mikrobielle infektionen
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
AU2003212466A1 (en) * 2002-02-28 2003-09-16 Board Of Regents, The University Of Texas System Method and composition for detecting early hiv antibody
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome

Also Published As

Publication number Publication date
EP0388602A1 (de) 1990-09-26
JPH02268696A (ja) 1990-11-02
JP2958346B2 (ja) 1999-10-06
CA2009198A1 (en) 1990-08-03
CA2009198C (en) 2000-02-01
DE69013950D1 (de) 1994-12-15
EP0388602B1 (de) 1994-11-09
US5374518A (en) 1994-12-20
ES2066887T3 (es) 1995-03-16
AU4906590A (en) 1990-09-20
DE69013950T2 (de) 1995-03-30

Similar Documents

Publication Publication Date Title
ATE113989T1 (de) Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen.
NO881719L (no) Syntetisk hiv-2-antigen.
ATE364621T1 (de) Hiv-peptide
AU637097B2 (en) Process for preparing an improved western blot immunoassay
EP0599417A3 (de) Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay.
EP0324849A4 (en) Method for rapid and sensitive detection of igm retroviral antibodies
DK0492560T3 (da) Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider
EP0602046A4 (de) Detektion des immunschwäche-virus aus säugetieren.
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
ATE137864T1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
SE8701765D0 (sv) Analysis method and means therefor
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
SE8701294D0 (sv) Hiv-peptid

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee